PMID- 29987125
OWN - NLM
STAT- MEDLINE
DCOM- 20191104
LR  - 20220410
IS  - 2047-9980 (Electronic)
IS  - 2047-9980 (Linking)
VI  - 7
IP  - 14
DP  - 2018 Jul 9
TI  - Periprocedural Cardiopulmonary Bypass or Venoarterial Extracorporeal Membrane 
      Oxygenation During Transcatheter Aortic Valve Replacement: A Systematic Review.
LID - 10.1161/JAHA.118.009608 [doi]
LID - e009608
AB  - BACKGROUND: There are limited data on the use of venoarterial extracorporeal 
      membrane oxygenation (VA-ECMO) or cardiopulmonary bypass (CPB) to provide 
      hemodynamic support periprocedurally during transcatheter aortic valve 
      replacement. This study sought to evaluate patients receiving transcatheter 
      aortic valve replacement with concomitant use of CPB/VA-ECMO. METHODS AND 
      RESULTS: We systematically reviewed the published literature from 2000 to 2018 
      for studies evaluating adult patients requiring CPB/VA-ECMO periprocedurally 
      during transcatheter aortic valve replacement. Studies reporting short-term and 
      long-term mortality were included. Given the significant methodological and 
      statistical differences between published studies, meta-analysis of the 
      association of CPB/VA-ECMO with mortality was not performed. Of the 537 studies 
      identified, 9 studies representing 5191 patients met our inclusion criteria. 
      Median ages were between 75 and 87 years with 33% to 75% male patients. Where 
      reported, the Edwards SAPIEN transcatheter heart valve was the most frequently 
      used. A total of 203 (3.9%) patients received periprocedural hemodynamic support 
      with CPB/VA-ECMO. Common indications for CPB/VA-ECMO included left ventricular or 
      aortic annular rupture, rapid hemodynamic deterioration, aortic regurgitation, 
      cardiac arrest, and left main coronary artery obstruction. The use of CPB/VA-ECMO 
      was predominantly an emergent strategy and was used for durations of 1 to 
      2 hours. Short-term mortality (in-hospital and 30-day) was 29.8%, and 1-year 
      mortality was 52.4%. Major complications such as bleeding, vascular injury, 
      tamponade, stroke, and renal failure were noted in 10% to 50% of patients. 
      CONCLUSIONS: CPB/VA-ECMO was used in 4% in the early experience of patients 
      undergoing transcatheter aortic valve replacement, most commonly for 
      periprocedural complications. There are limited data on preprocedural planned use 
      of VA-ECMO, and the characteristics of this population remain poorly defined.
CI  - (c) 2018 The Authors. Published on behalf of the American Heart Association, Inc., 
      by Wiley.
FAU - Vallabhajosyula, Saraschandra
AU  - Vallabhajosyula S
AD  - Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
FAU - Patlolla, Sri Harsha
AU  - Patlolla SH
AD  - Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
FAU - Sandhyavenu, Harigopal
AU  - Sandhyavenu H
AD  - Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
FAU - Vallabhajosyula, Saarwaani
AU  - Vallabhajosyula S
AD  - Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
FAU - Barsness, Gregory W
AU  - Barsness GW
AD  - Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
FAU - Dunlay, Shannon M
AU  - Dunlay SM
AD  - Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
FAU - Greason, Kevin L
AU  - Greason KL
AD  - Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN.
FAU - Holmes, David R Jr
AU  - Holmes DR Jr
AD  - Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
FAU - Eleid, Mackram F
AU  - Eleid MF
AD  - Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 
      eleid.mackram@mayo.edu.
LA  - eng
PT  - Journal Article
PT  - Systematic Review
DEP - 20180709
PL  - England
TA  - J Am Heart Assoc
JT  - Journal of the American Heart Association
JID - 101580524
SB  - IM
MH  - Aortic Valve/*surgery
MH  - Aortic Valve Stenosis/*surgery
MH  - Cardiopulmonary Bypass/*methods
MH  - Extracorporeal Membrane Oxygenation/*methods
MH  - Global Health
MH  - Humans
MH  - Incidence
MH  - Postoperative Complications/*epidemiology
MH  - Transcatheter Aortic Valve Replacement/*methods
PMC - PMC6064861
OTO - NOTNLM
OT  - cardiogenic shock
OT  - cardiopulmonary bypass
OT  - critical care
OT  - mechanical circulatory support
OT  - transcatheter valve implantation
EDAT- 2018/07/11 06:00
MHDA- 2019/11/05 06:00
PMCR- 2018/07/17
CRDT- 2018/07/11 06:00
PHST- 2018/07/11 06:00 [entrez]
PHST- 2018/07/11 06:00 [pubmed]
PHST- 2019/11/05 06:00 [medline]
PHST- 2018/07/17 00:00 [pmc-release]
AID - JAHA.118.009608 [pii]
AID - JAH33350 [pii]
AID - 10.1161/JAHA.118.009608 [doi]
PST - epublish
SO  - J Am Heart Assoc. 2018 Jul 9;7(14):e009608. doi: 10.1161/JAHA.118.009608.